Clinical Study
Characteristics and Patterns of Metastatic Disease from Chordoma
Table 6
Survival distribution among patients with metastasis stratified by location of metastatic disease.
(a) Case processing summary of patients included in analysis |
| Location of primary metastasis | Total | of events | Censored | | Percent |
| Bone | 3 | 3 | 0 | 0% | Liver | 2 | 1 | 1 | 50.0% | Lung | 16 | 14 | 2 | 12.5% | Soft tissue | 1 | 1 | 0 | 0% |
| Overall | 22 | 19 | 3 | 13.6% |
|
|
(b) Overall statistical comparison and test of equality of survival distributions |
| | Chi-Square | df | Sig. |
| Log rank (Mantel-Cox) | 11.260 | 3 | 0.010 |
|
|
(c) Means and medians for survival time. Estimation is limited to the largest survival time if it is censored |
| Location of primary metastasis | Mean | | Median | | | 95% Conf. interval | | | | 95% Conf. interval | Estimate | Std. error | Lower bound | Upper bound | | Estimate | Std. error | Lower bound | Upper bound |
| Bone | 48 | 8.2 | 32 | 64 | | 46 | 8.9 | 28.4 | 63.6 | Liver | 81 | 6 | 68.7 | 92.3 | | 72 | N/A | N/A | N/A | Lung | 123.3 | 15.7 | 92.6 | 154.1 | | 130 | 1.8 | 126.4 | 133.6 | Soft tissue | 133 | 0 | 133 | 133 | | 132 | N/A | N/A | N/A |
| Overall | 111.6 | 13.1 | 86 | 137.4 | | 128 | 16.8 | 97.1 | 163 |
|
|